VASCO & Gemalto- Markman Hearing held on August 30,

New Post Public Reply Private Reply Replies (0) Message Board
zpaul Splithappens #2265
268
VASCO & Gemalto- Markman Hearing held on August 30, 2017
Quote:
You do not have access to this transcript.

Transcript of Markman Hearing held on August 30, 2017 , before Judge Richard G. Stearns. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Marcia Patrisso at m.patrisso@outlook.com Redaction Request due 9/27/2017. Redacted Transcript Deadline set for 10/10/2017. Release of Transcript Restriction set for 12/5/2017. Associated Cases: 1:17-cv-10423-RGS, 1 :17-cv-10422-RGS(Scalfani, Deborah)

Quote:
Full docket text for document 56:
NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at www.mad.uscourts.gov/attorneys/general-info.htm Associated Cases: 1:17-cv-10423-RGS, 1:17-cv-10422-RGS(Scalfani, Deborah)

Redaction Policy: http://www.njd.uscourts.gov/sites/njd/files/P...cripts.pdf

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors

Updated Category News Views 183

Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...

Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low

Updated Category News Views 120

Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 159

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion

Updated Category News Views 82

Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...

Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future

Updated Category News Views 8

Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...

Continue Reading